<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Food Sci Nutr</journal-id><journal-id journal-id-type="iso-abbrev">Food Sci Nutr</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2048-7177</journal-id><journal-id journal-id-type="publisher-id">FSN3</journal-id><journal-title-group><journal-title>Food Science &#x00026; Nutrition</journal-title></journal-title-group><issn pub-type="epub">2048-7177</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7802582</article-id><article-id pub-id-type="doi">10.1002/fsn3.2021</article-id><article-id pub-id-type="publisher-id">FSN32021</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>In vitro and in vivo <italic>Anti&#x02010;Toxoplasma</italic> activity of <italic>Dracocephalum kotschyi</italic> essential oil</article-title><alt-title alt-title-type="left-running-head">KHAMESIPOUR et al.</alt-title></title-group><contrib-group><contrib id="fsn32021-cr-0001" contrib-type="author" corresp="yes"><name><surname>Khamesipour</surname><given-names>Faham</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0678-2528</contrib-id><xref ref-type="aff" rid="fsn32021-aff-0001">
<sup>1</sup>
</xref><address><email>faham.khamesipour@yahoo.com</email></address></contrib><contrib id="fsn32021-cr-0002" contrib-type="author" corresp="yes"><name><surname>Razavi</surname><given-names>Seyed Mostafa</given-names></name><xref ref-type="aff" rid="fsn32021-aff-0001">
<sup>1</sup>
</xref><address><email>mrazavi@shirazu.ac.ir</email></address></contrib><contrib id="fsn32021-cr-0003" contrib-type="author"><name><surname>Hejazi</surname><given-names>Seyed Hossein</given-names></name><xref ref-type="aff" rid="fsn32021-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="fsn32021-cr-0004" contrib-type="author"><name><surname>Ghanadian</surname><given-names>Seyed Mustafa</given-names></name><xref ref-type="aff" rid="fsn32021-aff-0003">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="fsn32021-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Pathobiology</named-content>
<named-content content-type="organisation-division">School of Veterinary Medicine</named-content>
<institution>Shiraz University</institution>
<city>Shiraz</city>
<country country="IR">Iran</country>
</aff><aff id="fsn32021-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Parasitology and Mycology</named-content>
<named-content content-type="organisation-division">Skin Diseases and Leishmaniasis Research Center</named-content>
<named-content content-type="organisation-division">School of Medicine</named-content>
<institution>Isfahan University of Medical Sciences</institution>
<city>Isfahan</city>
<country country="IR">Iran</country>
</aff><aff id="fsn32021-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Pharmacognosy</named-content>
<named-content content-type="organisation-division">Isfahan Pharmaceutical Sciences Research Center</named-content>
<institution>Isfahan University of Medical Sciences</institution>
<city>Isfahan</city>
<country country="IR">Iran</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Faham Khamesipour and Seyed Mostafa Razavi, Department of Pathobiology, School of Veterinary Medicine, Shiraz University, P.O. Box: 71345 1731, Shiraz, Iran.<break/>
Email: <email>faham.khamesipour@yahoo.com</email>; <email>mrazavi@shirazu.ac.ir</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2021</year></pub-date><volume>9</volume><issue>1</issue><issue-id pub-id-type="doi">10.1002/fsn3.v9.1</issue-id><fpage>522</fpage><lpage>531</lpage><history><date date-type="received"><day>12</day><month>9</month><year>2020</year></date><date date-type="rev-recd"><day>31</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>02</day><month>11</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright">&#x000a9; 2021 The Authors. Food Science & Nutrition published by Wiley Periodicals LLC.<copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2020 The Authors. <italic>Food Science &#x00026; Nutrition</italic> published by Wiley Periodicals LLC</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:FSN3-9-522.pdf"/><abstract id="fsn32021-abs-0001"><title>Abstract</title><p>
<italic>Toxoplasma gondii</italic> is a zoonotic parasite of worldwide importance, responsible for toxoplasmosis in homeotherms. Although treatment options are readily available, most drugs often cause serious side effects. Extracts of <italic>Dracocephalum kotschyi</italic> (<italic>D.&#x000a0;kotschyi</italic>) have shown significant pharmacological activity against various parasites, viruses, and bacteria. In this study, we evaluated the anti&#x02010;<italic>T.&#x000a0;gondii</italic> activity in vitro and in vivo of <italic>D.&#x000a0;kotschyi</italic> essential oil. The thiazolyl blue tetrazolium bromide (MTT) method was used to assess the anti&#x02010;<italic>T.&#x000a0;gondii</italic> activity and cytotoxicity of the essential oil. The presence of <italic>T.&#x000a0;gondii</italic> was observed by Giemsa staining, and the viability was evaluated by the trypan blue staining method. Furthermore, the survival rate of acutely infected mice was evaluated by intraperitoneal injecting of the essential oil (50, 100, and 200&#x000a0;mg&#x000a0;kg<sup>&#x02212;1</sup>&#x000a0;day<sup>&#x02212;1</sup>) for five days after infection with 2&#x000a0;&#x000d7;&#x000a0;10<sup>4</sup> tachyzoites. Essential oil, negative, and positive controls that showed the best toxoplasmacidal activity were assayed in triplicate at each concentration. The essential oil exhibited the highest anti&#x02010;<italic>Toxoplasma</italic> activity with a half&#x02010;maximal inhibitory concentration (IC<sub>50</sub>)&#x000a0;of 9.94&#x000a0;&#x000b1;&#x000a0;0.38&#x000a0;&#x000b5;g, with a selectivity index of 2.463. On Vero cells, the CC<sub>50</sub>&#x000a0;of the oil was 24.49&#x000a0;&#x000b1;&#x000a0;0.96&#x000a0;&#x000b5;g and exhibited a significant anti&#x02010;<italic>Toxoplasma</italic> activity. Moreover, the treatment by essential oil significantly increased the survival rate compared to untreated infected control. In conclusion, the essential oil might be a useful compound, and with more testing, it may be an excellent alternative to standard chemical drugs in the treatment of toxoplasmosis.</p></abstract><abstract abstract-type="graphical" id="fsn32021-abs-0002"><p>The results obtained in this study attribute to the essential oil of <italic>D. kotschyi</italic>, inhibitory activity against <italic>T. gondii</italic>, without toxicity to the host.<boxed-text position="anchor" content-type="graphic" id="fsn32021-blkfxd-0001" orientation="portrait"><graphic xlink:href="FSN3-9-522-g005.jpg" position="anchor" id="nlm-graphic-1" orientation="portrait"/></boxed-text>
</p></abstract><kwd-group><kwd id="fsn32021-kwd-0001">anti&#x02010;<italic>T. gondii</italic> activity</kwd><kwd id="fsn32021-kwd-0002">cytotoxicity</kwd><kwd id="fsn32021-kwd-0003"><italic>Dracocephalum kotschyi</italic></kwd><kwd id="fsn32021-kwd-0004">essential oil</kwd><kwd id="fsn32021-kwd-0005"><italic>Toxoplasma gondii</italic></kwd></kwd-group><counts><fig-count count="5"/><table-count count="3"/><page-count count="10"/><word-count count="6803"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January 2021</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.6 mode:remove_FC converted:12.01.2021</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="fsn32021-cit-1001">
<string-name>
<surname>Khamesipour</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Razavi</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Hejazi</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Ghanadian</surname>
<given-names>SM</given-names>
</string-name>. <article-title>In vitro and in vivo <italic>Anti&#x02010;Toxoplasma</italic> activity of <italic>Dracocephalum kotschyi</italic> essential oil</article-title>. <source xml:lang="en">Food Sci Nutr</source>.<year>2021</year>;<volume>9</volume>:<fpage>522</fpage>&#x02013;<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1002/fsn3.2021</pub-id>
</mixed-citation>
</p></notes></front><body id="fsn32021-body-0001"><sec id="fsn32021-sec-0001"><label>1</label><title>INTRODUCTION</title><p>
<italic>Toxoplasma gondii</italic> is a protozoan that causes zoonosis in most homeothermic animals (Khamesipour et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0023" ref-type="ref">2014</xref>; McAuley,&#x000a0;<xref rid="fsn32021-bib-0027" ref-type="ref">2014</xref>). The leading cause of infection due to the consumption of water or food contaminated by oocysts of the parasite, excreted by cats. Also, undercooked consumption containing tissue cysts can lead to transmission to humans. Primary infection is usually sub&#x02010;clinical. However, in the most severe cases, the manifestations may be eye disease or cervical lymphadenopathy. Maternal infection may also occur during pregnancy. The consequences can be severe for the fetus (Dunay et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0013" ref-type="ref">2018</xref>). In animals, this can lead to abortion, weak newborns, or deformities (Weissmann,&#x000a0;<xref rid="fsn32021-bib-0044" ref-type="ref">2003</xref>).</p><p>The treatment of toxoplasmosis involves anti&#x02010;parasitic drugs that act primarily against the tachyzoite form; they do not eradicate the encysted (bradyzoite) stage. The most effective agent is the pyrimethamine, which is used in most drug regimens (Dunay et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0013" ref-type="ref">2018</xref>). However, leucovorin must be given concomitantly to prevent bone marrow suppression. The efficacy of trimethoprim, azithromycin, dapsone, clarithromycin, contrimaxole, atovaquone, and sulfamethoxazole is unclear; therefore, it is recommended that they are used only in combination with pyrimethamine (Dunay et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0013" ref-type="ref">2018</xref>; Rajapakse et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0035" ref-type="ref">2013</xref>). Of the available combinations, the most effective include pyrimethamine and sulfadiazine or trisulfapyrimidines. However, these combinations have many side effects that hamper their use. Hypersensitivity reactions, megaloblastic anemia, bone marrow damage, and agranulocytosis are inevitable in many cases (De La Torre et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0010" ref-type="ref">2014</xref>; Guaraldo et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0016" ref-type="ref">2018</xref>). Therefore, it is necessary to find new, less toxic drugs for the treatment of this infection.</p><p>Increasingly, natural substances derived from medicinal plants are an essential source of drugs for clinical use. For example, therapeutic properties and active substances to <italic>D.&#x000a0;kotschyi</italic> (Heydari et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0017" ref-type="ref">2019</xref>). The medicinal plant contains different essential oils compounds, such as citral, &#x003b1;&#x02010;pinene, caryophyllene, Gerania, terpinyl, 1,1&#x02010;dimethoxydecane, geranial, limonene&#x02010;10&#x02010;al, acetate, terpinen&#x02010;4&#x02010;ol, limonene, &#x003b1;&#x02010;terpineol, &#x003b4;&#x02010;3&#x02010;carene, and others (Heydari et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0017" ref-type="ref">2019</xref>; Sadraei et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0036" ref-type="ref">2016</xref>), and flavonoids such as xanthomicrol, apigenin 4&#x02032;&#x02010;O&#x02010;&#x003b2;&#x02010;<sc>d</sc>&#x02010;glucopyranoside, acacetin 7&#x02010;O&#x02010;&#x003b2;&#x02010;<sc>d</sc>&#x02010;glucopyranoside, calycopterin, isokaempferide, luteolin, apigenin, luteolin 7&#x02010;O&#x02010;&#x003b2;&#x02010;<sc>d</sc>&#x02010;glucopyranoside, luteolin 3&#x02032;&#x02010;O&#x02010;&#x003b2;&#x02010;<sc>d</sc>&#x02010;glucuronide (Fattahi &#x00026; Nazeri,&#x000a0;<xref rid="fsn32021-bib-0014" ref-type="ref">2013</xref>; Gohari et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0015" ref-type="ref">2003</xref>; Saeidnia et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0037" ref-type="ref">2005</xref>; Saeidnia et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0038" ref-type="ref">2004</xref>; Zeng et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0045" ref-type="ref">2010</xref>), limonen&#x02010;10&#x02010;al, and limonene, among others (Jalaei &#x00026; Fattahi,&#x000a0;<xref rid="fsn32021-bib-0018" ref-type="ref">2015</xref>; Javidnia et al, <xref rid="fsn32021-bib-0019" ref-type="ref">2005</xref>). Besides, essential oil from shoots is one of the main active ingredients of <italic>D.&#x000a0;kotschyi</italic> (Heydari et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0017" ref-type="ref">2019</xref>) and has various pharmacological activities, including anti&#x02010;inflammatory (Sadraei et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0036" ref-type="ref">2016</xref>) and anticancer activities (Fattahi &#x00026; Nazeri,&#x000a0;<xref rid="fsn32021-bib-0014" ref-type="ref">2013</xref>).</p><p>Although several scientific works have demonstrated the potential medicinal effect of <italic>D.&#x000a0;Kotschyi</italic> essential oil on several pathogens, few data are available about its anti&#x02010;parasitic activity. Some flavonoid isolated from <italic>D.&#x000a0;Kotschyi</italic> essential oil had trypanocidal properties on <italic>Trypanosoma cruzi</italic> epimastigotes (Gohari et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0015" ref-type="ref">2003</xref>), but there is, to our knowledge, no data relating to the anti&#x02010;Toxoplasma properties of the plant. Given the therapeutic failure and severe side effects of the synthetic drugs available against many pathogens, safer therapeutic options must be explored. Incidentally, the use of essential oils to control parasitic pathogens could be useful in the fight against various infectious diseases. Here, we studied the activity of <italic>D.&#x000a0;Kotschyi</italic> essential oil against <italic>T.&#x000a0;gondii</italic> tachyzoites.</p></sec><sec sec-type="materials-and-methods" id="fsn32021-sec-0002"><label>2</label><title>MATERIALS AND METHODS</title><sec id="fsn32021-sec-0003"><label>2.1</label><title>Ethics approval</title><p>All applicable international and institutional guidelines for conducting the study. The study protocol was approved by the ethical committee of Shiraz University (IR.Shirazu.REC.1399.1214). The guideline of the Institutional Animal and Ethics Committee, Shiraz University, was used to work in this study.</p></sec><sec id="fsn32021-sec-0004"><label>2.2</label><title>Plant material</title><p>Plant samples were collected from the province of Isfahan, Iran, in October 2019. Authentication was carried out by the Department of Pharmacognosy. A voucher specimen was deposited in the School of Pharmacy herbarium (No. 1519). After drying in the shade, the plant organs were mechanically sprayed using an electric blender.</p></sec><sec id="fsn32021-sec-0005"><label>2.3</label><title>Preparation of essential oil</title><p>The drying of the aerial parts of the plants was carried out at room temperature, in the shade. The essential oils were obtained by hydrodistillation using a Clevenger device for 3&#x000a0;hr. The oil was dissolved in hexane (Merck, Darmstadt, Germany), dried on anhydrous sodium sulfate, and stored at 4&#x02013;6&#x000b0;C in sealed vials in the dark (Sonboli et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0043" ref-type="ref">2019</xref>).</p></sec><sec id="fsn32021-sec-0006"><label>2.4</label><title>Gas chromatography&#x02010;mass spectrometry (GC/MS) analysis</title><p>An Agilent 7890A GC coupled with an Agilent 5975C mass detector with triple quadrupole mass analyzer and electronic ionization (EI) was used for the GC analysis of the essential oil. The gas chromatograph was prepared with an HP&#x02010;5 GC capillary column (30&#x000a0;m&#x000a0;&#x000d7;&#x000a0;0.25&#x000a0;mm; film thickness 0.25&#x000a0;&#x003bc;m). The oven temperature was started from 50 &#x000ba;C, held for 2&#x000a0;min, raised by 8&#x000ba;C/min up to 250&#x000b0;C, followed by 250&#x02013;330&#x000b0;C by 3&#x000ba;C/min with the total run time of 58&#x000a0;min. The carrier gas was helium was at a flow rate of 2&#x000a0;ml/min. The temperature used for the injector and the detector is 280&#x000b0;C. The parameters for MS were as follows: ion source temperature (230&#x000b0;C), mass range (50&#x02013;700), ionization voltage (70 Ev). The MSD ChemStation was used as operating software. A comparison of mass spectra and retention times with literature data helped to identify compounds (Javidnia et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0019" ref-type="ref">2005</xref>).</p></sec><sec id="fsn32021-sec-0007"><label>2.5</label><title>Tachyzoites multiplication, quantitation, and maintenance</title><p>Tachyzoites of <italic>T.&#x000a0;gondii</italic> RH strain were maintained by intraperitoneal passages in Balb/c mice and collected in phosphate&#x02010;buffered saline (PBS), pH 7.2, at 3&#x02013;4&#x000a0;day intervals. Peritoneal fluid was obtained from the infected mice and centrifuged for 10&#x000a0;min at 200&#x000a0;<bold><italic>g</italic></bold> at room temperature. This centrifugation removed host cells and debris. Subsequently, the supernatant containing the parasites was collected and centrifuged for 10&#x000a0;min at 1,000&#x000a0;<bold><italic>g</italic></bold>. The pellet was washed in two stages, first with PBS at pH 7.2 and then RPMI&#x02010;1640 (Gibco, USA) without bovine fetal serum.</p><p>The viability of the parasites was assessed 30 to 40&#x000a0;min after removal from the peritoneal cavity, using the trypan blue exclusion method. To determine the number of tachyzoites, light microscopy with a hemocytometer was used. The tachyzoites were inoculated into a 75&#x02010;ml tissue culture flask containing proliferative Vero cells in a humidified 5% CO<sub>2</sub> incubator at 37&#x000b0;C (Bajelan et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0004" ref-type="ref">2020</xref>).</p></sec><sec id="fsn32021-sec-0008"><label>2.6</label><title>Animal model</title><p>The animal testing work was carried out under international standards. Inbred Balb/c mice were used. The weight of the animals is between 18 and 20&#x000a0;g. The animals were kept in cages under standard laboratory conditions at an average temperature of 20&#x02013;25&#x000b0;C. During the experiment, the animals had regular access to drinking water and foods.</p></sec><sec id="fsn32021-sec-0009"><label>2.7</label><title>Vero cells</title><p>The kidney cell lines "Vero" were initiated from a green monkey kidney and were obtained from the National Cell Bank of Iran (NCBI, Pasteur Institute of Iran, Tehran, Iran). Vero cells were maintained and cultures at 37&#x000b0;C with 5% CO<sub>2</sub>, in RPMI&#x02010;1640 medium supplemented with 100&#x003bc;g/ml streptomycin, 100 units/ml penicillin (Gibco, Pen&#x02010;Strep15140), 2 raM <sc>l</sc>&#x02010;glutamine, and 10% fetal bovine serum (FBS) (Bovogen, Australia).</p></sec><sec id="fsn32021-sec-0010"><label>2.8</label><title>Cytotoxicity assessment</title><p>The cytotoxicity of the essential oil was evaluated on Vero cells with a modification of the MTT test (Sigma&#x02010;Aldrich, USA) with 3&#x02010;(4, 5&#x02010;dimethylthiazol&#x02010;2&#x02010;yl)&#x02010;2,5&#x02010;diphenyltetrazolium bromide, described by Mosmann (Mosmann,&#x000a0;<xref rid="fsn32021-bib-0031" ref-type="ref">1983</xref>), using 96&#x02010;well plates. 6&#x000a0;&#x000d7;&#x000a0;10<sup>4</sup> cells/mL of Vero cells were inoculated into each well previously containing 100&#x003bc;L growth medium. Incubation at 37&#x000ba;C followed in an incubator moistened with 5% CO<sub>2</sub> for 24&#x000a0;hr. After this incubation, the Vero cells were treated with extracts of <italic>D.&#x000a0;kotschyi</italic> at different concentrations: 1,000, 500, 100, 50, 10, and 1&#x000a0;&#x003bc;g. Each concentration was added to each respective 96&#x02010;well plate. Pyrimethamine and sulfadiazine (reference drugs used in the treatment of toxoplasmosis) were used as positive controls while RPMI&#x02010;1640 was used as a control buffer. After 24&#x000a0;hr, the supernatant was removed. 100&#x000a0;&#x003bc;l of the MTT&#x02010;PBS solution (5&#x000a0;mg/ml) in RPMI&#x02010;1640 in a 1:9 ratios in each well. The plate was then covered with aluminum foil and incubated for 4&#x000a0;hr in a 37&#x000ba; C incubator. The medium was then discarded, and 100&#x000a0;&#x003bc;l of DMSO was added to each well to solubilize the dark blue MTT formazan salt. The optical density was measured at an absorbance of 570&#x000a0;nm using a Dynex microplate reader.</p></sec><sec id="fsn32021-sec-0011"><label>2.9</label><title>In vitro&#x000a0;infection and MTT test</title><p>Vero cells were used for this step. The cells were obtained by exponential growth. 3&#x000a0;&#x000d7;&#x000a0;10<sup>5</sup> parasites/ml was deposited in each well to have a final volume of 200&#x000a0;&#x000b5;l (Belloni et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0005" ref-type="ref">2003</xref>). The infected cells were then washed with RPMI&#x02010;1640 FBS&#x02010;free medium (twice), six hours after inoculation, to remove extracellular parasites. After incubation for 18&#x000a0;hr, 100&#x000a0;&#x003bc;l of RPMI&#x02010;1640 medium with 2% FBS were added to each well with different concentrations of essential oil/pyrimethamine and sulfadiazine (to a final concentration of 1&#x02010;1000&#x003bc;g) (Sheng&#x02010;Xia et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0042" ref-type="ref">2008</xref>). The treatment lasted 24&#x000a0;hr, the anti&#x02010;<italic>T.&#x000a0;gondii</italic> activity and the cytotoxicity of the essential oil were determined by a thiazolyl blue tetrazolium bromide (MTT) method in 96&#x02010;well plates (Sigma, St. Louis, MO, USA). The essential oil was added to the cell line. After 24&#x000a0;hr, the MTT solution was added to the cells, and the presence of purple matrices was analyzed using a plate reader. All data points represent the average of three independent experiments. The mean inhibitory concentration (IC<sub>50</sub>) was determined based on the concentration of extracts, controls, and essential oil that successfully inhibited 50% of the <italic>T.&#x000a0;gondii</italic> tachyzoites. Selectivity is the mean IC<sub>50</sub> value for Vero cells relative to the mean IC<sub>50</sub> value for <italic>T.&#x000a0;gondii</italic> (Park et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0033" ref-type="ref">2003</xref>).<disp-formula id="fsn32021-disp-0001"><mml:math id="nlm-math-1"><mml:mrow><mml:mtext>SI</mml:mtext><mml:mfenced close=")" open="(" separators=""><mml:mo>%</mml:mo></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi mathvariant="normal">V</mml:mi><mml:mo>&#x02010;</mml:mo><mml:msub><mml:mtext>IC</mml:mtext><mml:mn>50</mml:mn></mml:msub><mml:mo stretchy="false">/</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mo>&#x02010;</mml:mo><mml:msub><mml:mtext>IC</mml:mtext><mml:mn>50</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mn>100</mml:mn></mml:mrow></mml:math></disp-formula>
</p><p>T&#x02010;IC<sub>50</sub> and V&#x02010;IC<sub>50</sub> are the median inhibitory concentrations required to inhibit <italic>T.&#x000a0;gondii</italic> and Vero cells, respectively.</p></sec><sec id="fsn32021-sec-0012"><label>2.10</label><title>Tachyzoite viability by&#x000a0;trypan blue&#x000a0;exclusion</title><p>Tachyzoite viability test was permed, in vitro using the method proposed by Cover and Gutteridge (Cover &#x00026; Gutteridge,&#x000a0;<xref rid="fsn32021-bib-0008" ref-type="ref">1982</xref>). 45&#x000a0;&#x003bc;l of tachyzoite suspension containing 10<sup>6</sup> cells/ml and <italic>D.&#x000a0;kotschyi</italic> essential oil at six different concentrations (1, 10, 50, 100, 500, and 1000&#x000b5;g) in 96&#x02010;well microplates are brought together. The whole is incubated at 37&#x000b0;C. After 30, 90, and 180&#x000a0;min incubation in 5% CO<sub>2</sub> at 37&#x000b0;C, a trypan blue dye exclusion test for tachyzoites is carried out under an inverted microscope. Results were expressed as % viability. Positive controls consisted of 96&#x02010;well plates containing pyrimethamine and sulfadiazine at a concentration of 100&#x000a0;mg/ml, while PBS were the negative controls. The plates were then spread on a glass slide followed by an examination under an optical microscope. The experiments were repeated three times.</p></sec><sec id="fsn32021-sec-0013"><label>2.11</label><title>Light microscopy of tachyzoites in cell lines</title><p>Vero cell culture (2 x 10<sup>5</sup> cells/ml) was carried out on a glass slide in a 35&#x000a0;mm cell culture dish up to the confluence and then infected with 1&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> tachyzoites/well. After 4&#x000a0;hr incubation, the monolayers were washed with Hanks' Balanced Saline Solution (HBSS; Gibco Inc., USA), followed by the addition of the essential oil contained in RPMI&#x02010;1640. The glass lids were removed from the dishes at 48&#x000a0;hr after adding the essential oil, pyrimethamine, sulphadiazine, and 1% DMSO (negative control). All glass slides were washed with HBSS and fixed with methanol before staining with Giemsa (Sigma Inc., USA). The samples were observed under an oil&#x02010;immersion objective lens at a magnification of 1,000&#x000a0;&#x000d7;&#x000a0;by an optical microscope. A camera and software were used to capture the images (Sheng&#x02010;Xia et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0042" ref-type="ref">2008</xref>).</p></sec><sec id="fsn32021-sec-0014"><label>2.12</label><title>In vivo toxoplasmicidal studies</title><p>For in vivo determination of anti&#x02010;<italic>Toxoplasma</italic> activity, 60 female Balb/c mice between 4 and 6&#x000a0;weeks of age were used. The animals received an intraperitoneal (IP) injection of <italic>T.&#x000a0;gondii</italic> RH (2&#x000a0;&#x000d7;&#x000a0;10<sup>4</sup> tachyzoites) and then divided into 6 groups of 10 mice (Ebrahimzadeh et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0009" ref-type="ref">2017</xref>). After inoculation, batch treatment was immediately started and continued for 5&#x000a0;days at regular 24&#x02010;hr intervals as follows: essential oil (200, 100, and 50&#x000a0;mg/kg&#x02010;1/day&#x02010;1), pyrimethamine (25&#x000a0;mg/kg&#x02010;1/day&#x02010;1), PBS (negative control), and sulfadiazine (500&#x000a0;mg&#x000a0;kg<sup>&#x02212;1</sup>&#x000a0;day<sup>&#x02212;1</sup>) (positive control). Regular daily monitoring of the mice was carried out throughout the experiment. Unusual observations and deaths of the mice were recorded. To avoid side effects of the drugs used, the experiment was preceded by a preliminary study in which Balb/c mice were given the same dose of drugs. No clinically significant toxicity or mortality was observed.</p></sec><sec id="fsn32021-sec-0015"><label>2.13</label><title>Statistical analysis</title><p>Statistical analysis was performed using ANOVA using SPSS software (ver 18.0). All values were expressed as the mean&#x000a0;&#x000b1;&#x000a0;<italic>SD</italic>, and the level of significance was assumed as&#x000a0;<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;.05.</p></sec></sec><sec sec-type="results" id="fsn32021-sec-0016"><label>3</label><title>RESULTS</title><sec id="fsn32021-sec-0017"><label>3.1</label><title>GC/MS analysis</title><p>As shown in Table&#x000a0;<xref rid="fsn32021-tbl-0001" ref-type="table">1</xref>, 11 substances were identified. They represent 91.5% of the oil. The main substances were Copaene (22.15%), Methyl geranate (16.31%), Geranial (13.78%), and Carvone (11.34%). Figure&#x000a0;<xref rid="fsn32021-fig-0001" ref-type="fig">1</xref> presents the typical total ion current chromatograms of the essential oil.</p><table-wrap id="fsn32021-tbl-0001" xml:lang="en" content-type="Table" orientation="portrait" position="float"><label>Table 1</label><caption><p>Chemical composition of the oil of <italic>Dracocephalum kotschyi</italic>
</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" colspan="2" valign="top" rowspan="1">Compound</th><th align="left" valign="top" rowspan="1" colspan="1">Molecular formula</th><th align="left" valign="top" rowspan="1" colspan="1">RI</th><th align="left" valign="top" rowspan="1" colspan="1">Rt (min)</th><th align="left" valign="top" rowspan="1" colspan="1">TIC (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>1</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>alpha&#x02010;Pinene</italic>
</td><td align="left" rowspan="1" colspan="1">C10H16</td><td align="left" rowspan="1" colspan="1">1,027</td><td align="char" char="." rowspan="1" colspan="1">3.7597</td><td align="char" char="." rowspan="1" colspan="1">4.8568</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">l&#x02010;Limonene</td><td align="left" rowspan="1" colspan="1">C10H16</td><td align="left" rowspan="1" colspan="1">1,090</td><td align="char" char="." rowspan="1" colspan="1">5.731</td><td align="char" char="." rowspan="1" colspan="1">3.3306</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">&#x003b1;&#x02010;Campholenal</td><td align="left" rowspan="1" colspan="1">C10H16O</td><td align="left" rowspan="1" colspan="1">1,126.5</td><td align="char" char="." rowspan="1" colspan="1">8.4237</td><td align="char" char="." rowspan="1" colspan="1">3.8666</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">trans&#x02010;Verbenol</td><td align="left" rowspan="1" colspan="1">C10H16O</td><td align="left" rowspan="1" colspan="1">1,145.91</td><td align="char" char="." rowspan="1" colspan="1">9.0193</td><td align="char" char="." rowspan="1" colspan="1">2.8767</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">cis&#x02010;Dihydrocarvone</td><td align="left" rowspan="1" colspan="1">C10H16O</td><td align="left" rowspan="1" colspan="1">1,196.46</td><td align="char" char="." rowspan="1" colspan="1">10.5712</td><td align="char" char="." rowspan="1" colspan="1">2.9758</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Carveol</td><td align="left" rowspan="1" colspan="1">C10H16O</td><td align="left" rowspan="1" colspan="1">1,223.15</td><td align="char" char="." rowspan="1" colspan="1">11.4436</td><td align="char" char="." rowspan="1" colspan="1">3.1408</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">Carvone</td><td align="left" rowspan="1" colspan="1">C10H14O</td><td align="left" rowspan="1" colspan="1">1,244.52</td><td align="char" char="." rowspan="1" colspan="1">12.1483</td><td align="char" char="." rowspan="1" colspan="1">11.3492</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">Chavicol</td><td align="left" rowspan="1" colspan="1">C9H10O</td><td align="left" rowspan="1" colspan="1">1,260.55</td><td align="char" char="." rowspan="1" colspan="1">12.6768</td><td align="char" char="." rowspan="1" colspan="1">6.8022</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">Geranial</td><td align="left" rowspan="1" colspan="1">C10H16O</td><td align="left" rowspan="1" colspan="1">1,275.81</td><td align="char" char="." rowspan="1" colspan="1">13.1801</td><td align="char" char="." rowspan="1" colspan="1">13.7829</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">Methyl geranate</td><td align="left" rowspan="1" colspan="1">C11H18O2</td><td align="left" rowspan="1" colspan="1">1,326.6</td><td align="char" char="." rowspan="1" colspan="1">14.841</td><td align="char" char="." rowspan="1" colspan="1">16.3141</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">Copaene</td><td align="left" rowspan="1" colspan="1">C15H24</td><td align="left" rowspan="1" colspan="1">1,387.09</td><td align="char" char="." rowspan="1" colspan="1">16.804</td><td align="char" char="." rowspan="1" colspan="1">22.1548</td></tr><tr><td align="left" colspan="5" rowspan="1">Monoterpenoids: Non&#x02010;oxygenated</td><td align="char" char="." rowspan="1" colspan="1">8.1874</td></tr><tr><td align="left" colspan="5" rowspan="1">Monoterpenoids: Oxygenated</td><td align="char" char="." rowspan="1" colspan="1">53.7701</td></tr><tr><td align="left" colspan="5" rowspan="1">Sesquiterpenoids</td><td align="char" char="." rowspan="1" colspan="1">22.1548</td></tr><tr><td align="left" colspan="5" rowspan="1">Phenyl propanoid</td><td align="char" char="." rowspan="1" colspan="1">6.8022</td></tr><tr><td align="left" colspan="5" rowspan="1">Minor Compounds less than 1%</td><td align="char" char="." rowspan="1" colspan="1">8.55</td></tr></tbody></table><table-wrap-foot id="fsn32021-ntgp-0001"><fn id="fsn32021-note-0001"><p>Abbreviations: RI, retention indices; Rt, retention time; TIC, total ion count.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><fig fig-type="Figure" xml:lang="en" id="fsn32021-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Typical GC&#x02010;MS total ion current (TIC) chromatograms</p></caption><graphic id="nlm-graphic-3" xlink:href="FSN3-9-522-g001"/></fig></sec><sec id="fsn32021-sec-0018"><label>3.2</label><title>Cytotoxicity activity and in vitro infection and effectors by MTT assay</title><p>The MTT assay showed that different concentrations of both essential oils of <italic>D.&#x000a0;kotschyi</italic> had no cytotoxicity comparatively with the negative control cells (Figure&#x000a0;<xref rid="fsn32021-fig-0002" ref-type="fig">2</xref> and Table&#x000a0;<xref rid="fsn32021-tbl-0002" ref-type="table">2</xref>). Thus, positive control and different concentrations of <italic>D.&#x000a0;kotschyi</italic> were used for further experiments against <italic>T.&#x000a0;gondii</italic> in vitro.</p><fig fig-type="Figure" xml:lang="en" id="fsn32021-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Effects of<italic>D.&#x000a0;kotschyi</italic>essential oil on the viability of<italic>T.&#x000a0;gondii</italic>tachyzoites</p></caption><graphic id="nlm-graphic-5" xlink:href="FSN3-9-522-g002"/></fig><table-wrap id="fsn32021-tbl-0002" xml:lang="en" content-type="Table" orientation="portrait" position="float"><label>Table 2</label><caption><p>In vitro IC50/ CC50 values for Vero cells (CC50 Vero&#x000a0;+&#x000a0;essential oil), anti&#x02010;<italic>T.&#x000a0;gondii</italic> RH strain activity and selectivity of <italic>D.&#x000a0;kotschyi</italic> essential oil, sulfadiazine, and pyrimethamine</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Tested drugs name</th><th align="left" valign="top" rowspan="1" colspan="1">
<p>Cytotoxicity (CC50, &#x000b5;g)</p>
<p>(Vero&#x000a0;+&#x000a0;essential oil)</p>
</th><th align="left" valign="top" rowspan="1" colspan="1">In vitro anti&#x02010;<italic>Toxoplasma</italic> assay (IC50, &#x000b5;g)</th><th align="left" valign="top" rowspan="1" colspan="1">Selectivity index (SI)<xref ref-type="fn" rid="fsn32021-note-0003">
<sup>a</sup>
</xref>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Essential oil</td><td align="char" char="." rowspan="1" colspan="1">24.49&#x000a0;&#x000b1;&#x000a0;0.96&#x000a0;&#x000b5;g</td><td align="char" char="." rowspan="1" colspan="1">9.94&#x000a0;&#x000b1;&#x000a0;0.38&#x000a0;&#x003bc;g</td><td align="char" char="." rowspan="1" colspan="1">2.463</td></tr><tr><td align="left" rowspan="1" colspan="1">Sulfadiazine (Positive control)</td><td align="char" char="." rowspan="1" colspan="1">607.18&#x000a0;&#x000b1;&#x000a0;0.89&#x000a0;&#x003bc;g</td><td align="char" char="." rowspan="1" colspan="1">391.18&#x000a0;&#x000b1;&#x000a0;0.97&#x000a0;&#x003bc;g</td><td align="char" char="." rowspan="1" colspan="1">1.552</td></tr><tr><td align="left" rowspan="1" colspan="1">Pyrimethamine (Positive control)</td><td align="char" char="." rowspan="1" colspan="1">342.23&#x000a0;&#x000b1;&#x000a0;0.99&#x000a0;&#x003bc;g</td><td align="char" char="." rowspan="1" colspan="1">84.20&#x000a0;&#x000b1;&#x000a0;0.93&#x000a0;&#x003bc;g</td><td align="char" char="." rowspan="1" colspan="1">4.064</td></tr></tbody></table><table-wrap-foot id="fsn32021-ntgp-0002"><title>Note</title><fn id="fsn32021-note-0002"><p>IC<sub>50</sub>, median inhibitory concentration.</p></fn><fn id="fsn32021-note-0003"><label><sup>a</sup></label><p>Ratio of the CC<sub>50</sub>&#x000a0;value for Vero cells to the IC50 value for&#x000a0;<italic>Toxoplasma gondii</italic>&#x000a0;tachyzoites.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>Table&#x000a0;<xref rid="fsn32021-tbl-0002" ref-type="table">2</xref>&#x000a0;and Figure&#x000a0;<xref rid="fsn32021-fig-0002" ref-type="fig">2</xref> presents the results of&#x000a0;in vitro&#x000a0;anti&#x02010;<italic>T.&#x000a0;gondii</italic>&#x000a0;activity and selectivity. The essential oil exhibited the highest toxicity against <italic>T.&#x000a0;gondii</italic> tachyzoites at 1,000&#x000a0;&#x003bc;g (Figure&#x000a0;<xref rid="fsn32021-fig-0002" ref-type="fig">2</xref>). The in vitro cytotoxicity assay indicated that the essential oil compounds had toxicity on the growth of <italic>T.&#x000a0;gondii</italic>&#x000a0;tachyzoites at concentrations as lower than 9.94&#x000a0;&#x000b1;&#x000a0;0.38&#x003bc;g with a selectivity index (SI) of 2.463. Cytotoxicity (CC50, &#x003bc;g) (Vero&#x000a0;+&#x000a0;essential oil) produced better activity against the cell line. The essential oil was&#x000a0;active against&#x000a0;<italic>T.&#x000a0;gondii</italic>&#x000a0;tachyzoites&#x000a0;with&#x000a0;an IC50 value&#x000a0;below 10&#x000a0;&#x000b5;g (Table&#x000a0;<xref rid="fsn32021-tbl-0002" ref-type="table">2</xref>).</p></sec><sec id="fsn32021-sec-0019"><label>3.3</label><title>Effects of essential oil on tachyzoites viability</title><p>Six concentrations (1, 10, 50, 100, 500, and 1,000&#x000a0;&#x000b5;g) of&#x000a0;<italic>D.&#x000a0;kotschyi</italic> essential oil were incubated for 30, 90, and 180&#x000a0;min. The trypan blue stain was used to assess the viability of the tachyzoites. The results showed that&#x000a0;<italic>D.&#x000a0;kotschyi</italic> has acceptable efficacy&#x000a0;in vitro, and the parasiticidal effect of essential oil was significantly better than positive control in all exposure times (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;.05) (Table&#x000a0;<xref rid="fsn32021-tbl-0003" ref-type="table">3</xref>).</p><table-wrap id="fsn32021-tbl-0003" xml:lang="en" content-type="Table" orientation="portrait" position="float"><label>Table 3</label><caption><p>Effects of essential oil on tachyzoite viability</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="bottom" colspan="1">Groups</th><th align="left" rowspan="2" valign="bottom" colspan="1">Concentrations &#x003bc;g</th><th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Time</th><th align="left" rowspan="2" valign="bottom" colspan="1">
<italic>p</italic>&#x02010;Value</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">30&#x000a0;min</th><th align="left" valign="bottom" rowspan="1" colspan="1">90&#x000a0;min</th><th align="left" valign="bottom" rowspan="1" colspan="1">180&#x000a0;min</th></tr></thead><tbody><tr><td align="left" rowspan="6" colspan="1">Essential oil</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">96.33&#x000a0;&#x000b1;&#x000a0;1.52</td><td align="char" char="." rowspan="1" colspan="1">90.66&#x000a0;&#x000b1;&#x000a0;1.15</td><td align="char" char="." rowspan="1" colspan="1">86.66&#x000a0;&#x000b1;&#x000a0;1.52</td><td align="left" rowspan="6" colspan="1">
<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;.05</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">95.00&#x000a0;&#x000b1;&#x000a0;1.00</td><td align="char" char="." rowspan="1" colspan="1">86.33&#x000a0;&#x000b1;&#x000a0;1.52</td><td align="char" char="." rowspan="1" colspan="1">82.66&#x000a0;&#x000b1;&#x000a0;2.08</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">50</td><td align="char" char="." rowspan="1" colspan="1">90.66&#x000a0;&#x000b1;&#x000a0;1.52</td><td align="char" char="." rowspan="1" colspan="1">86.66&#x000a0;&#x000b1;&#x000a0;1.52</td><td align="char" char="." rowspan="1" colspan="1">80.00&#x000a0;&#x000b1;&#x000a0;2.00</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">100</td><td align="char" char="." rowspan="1" colspan="1">90.33&#x000a0;&#x000b1;&#x000a0;1.15</td><td align="char" char="." rowspan="1" colspan="1">81.00&#x000a0;&#x000b1;&#x000a0;1.00</td><td align="char" char="." rowspan="1" colspan="1">78.33&#x000a0;&#x000b1;&#x000a0;2.51</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">500</td><td align="char" char="." rowspan="1" colspan="1">87.33&#x000a0;&#x000b1;&#x000a0;1.15</td><td align="char" char="." rowspan="1" colspan="1">77.00&#x000a0;&#x000b1;&#x000a0;2.00</td><td align="char" char="." rowspan="1" colspan="1">70.66&#x000a0;&#x000b1;&#x000a0;2.51</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">1,000</td><td align="char" char="." rowspan="1" colspan="1">79.66&#x000a0;&#x000b1;&#x000a0;1.15</td><td align="char" char="." rowspan="1" colspan="1">72.66&#x000a0;&#x000b1;&#x000a0;2.08</td><td align="char" char="." rowspan="1" colspan="1">63.66&#x000a0;&#x000b1;&#x000a0;2.51</td></tr><tr><td align="left" rowspan="6" colspan="1">Sulfadiazine (Positive control)</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">97.66&#x000a0;&#x000b1;&#x000a0;0. 57</td><td align="char" char="." rowspan="1" colspan="1">92.33&#x000a0;&#x000b1;&#x000a0;1.52</td><td align="char" char="." rowspan="1" colspan="1">90.66&#x000a0;&#x000b1;&#x000a0;1.52</td><td align="left" rowspan="6" colspan="1">
<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;.05</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">97.33&#x000a0;&#x000b1;&#x000a0;0.57</td><td align="char" char="." rowspan="1" colspan="1">96.00&#x000a0;&#x000b1;&#x000a0;1.00</td><td align="char" char="." rowspan="1" colspan="1">90.00&#x000a0;&#x000b1;&#x000a0;1.00</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">50</td><td align="char" char="." rowspan="1" colspan="1">95.66&#x000a0;&#x000b1;&#x000a0;1.52</td><td align="char" char="." rowspan="1" colspan="1">94.66&#x000a0;&#x000b1;&#x000a0;0.57</td><td align="char" char="." rowspan="1" colspan="1">88.66&#x000a0;&#x000b1;&#x000a0;1.15</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">100</td><td align="char" char="." rowspan="1" colspan="1">95.00&#x000a0;&#x000b1;&#x000a0;2.00</td><td align="char" char="." rowspan="1" colspan="1">89.66&#x000a0;&#x000b1;&#x000a0;1.52</td><td align="char" char="." rowspan="1" colspan="1">87.66&#x000a0;&#x000b1;&#x000a0;1.52</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">500</td><td align="char" char="." rowspan="1" colspan="1">93.66&#x000a0;&#x000b1;&#x000a0;1.52</td><td align="char" char="." rowspan="1" colspan="1">87.33&#x000a0;&#x000b1;&#x000a0;2.08</td><td align="char" char="." rowspan="1" colspan="1">85.66&#x000a0;&#x000b1;&#x000a0;2.08</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">1,000</td><td align="char" char="." rowspan="1" colspan="1">90.33&#x000a0;&#x000b1;&#x000a0;2.08</td><td align="char" char="." rowspan="1" colspan="1">84.66&#x000a0;&#x000b1;&#x000a0;1.52</td><td align="char" char="." rowspan="1" colspan="1">79.33&#x000a0;&#x000b1;&#x000a0;1.52</td></tr><tr><td align="left" rowspan="6" colspan="1">Pyrimethamine (Positive control)</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">95.66&#x000a0;&#x000b1;&#x000a0;1.52</td><td align="char" char="." rowspan="1" colspan="1">92.00&#x000a0;&#x000b1;&#x000a0;2.00</td><td align="char" char="." rowspan="1" colspan="1">84.66&#x000a0;&#x000b1;&#x000a0;2.51</td><td align="left" rowspan="6" colspan="1">
<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;.05</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">93.33&#x000a0;&#x000b1;&#x000a0;2.08</td><td align="char" char="." rowspan="1" colspan="1">87.33&#x000a0;&#x000b1;&#x000a0;2.08</td><td align="char" char="." rowspan="1" colspan="1">81.66&#x000a0;&#x000b1;&#x000a0;2.08</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">50</td><td align="char" char="." rowspan="1" colspan="1">93.33&#x000a0;&#x000b1;&#x000a0;3.05</td><td align="char" char="." rowspan="1" colspan="1">84.33&#x000a0;&#x000b1;&#x000a0;3.51</td><td align="char" char="." rowspan="1" colspan="1">77.33&#x000a0;&#x000b1;&#x000a0;2.51</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">100</td><td align="char" char="." rowspan="1" colspan="1">92.00&#x000a0;&#x000b1;&#x000a0;2.00</td><td align="char" char="." rowspan="1" colspan="1">84.33&#x000a0;&#x000b1;&#x000a0;1.52</td><td align="char" char="." rowspan="1" colspan="1">76.66&#x000a0;&#x000b1;&#x000a0;1.52</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">500</td><td align="char" char="." rowspan="1" colspan="1">90.00&#x000a0;&#x000b1;&#x000a0;2.00</td><td align="char" char="." rowspan="1" colspan="1">80.33&#x000a0;&#x000b1;&#x000a0;2.51</td><td align="char" char="." rowspan="1" colspan="1">75.33&#x000a0;&#x000b1;&#x000a0;2.51</td></tr><tr><td align="char" char="." rowspan="1" colspan="1">1,000</td><td align="char" char="." rowspan="1" colspan="1">86.33&#x000a0;&#x000b1;&#x000a0;1.52</td><td align="char" char="." rowspan="1" colspan="1">75.33&#x000a0;&#x000b1;&#x000a0;2.08</td><td align="char" char="." rowspan="1" colspan="1">73.00&#x000a0;&#x000b1;&#x000a0;3.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Negative</td><td align="char" char="." rowspan="1" colspan="1">&#x02010;</td><td align="char" char="." rowspan="1" colspan="1">97.00&#x000a0;&#x000b1;&#x000a0;1.00</td><td align="char" char="." rowspan="1" colspan="1">95.33&#x000a0;&#x000b1;&#x000a0;2.51</td><td align="char" char="." rowspan="1" colspan="1">95.33&#x000a0;&#x000b1;&#x000a0;1.15</td><td align="left" rowspan="1" colspan="1">
<italic>p</italic>&#x000a0;&#x0003e;&#x000a0;.05</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>This essential oil at the concentration of 1&#x000a0;&#x000b5;g killed 96.33, 90.66, and 86.66% of tachyzoites after 30, 90, and 180&#x000a0;min, respectively. The concentration of 1,000&#x000a0;&#x000b5;g died 79.66, 72.66, and 63.66% of tachyzoites after 30, 90, and 180&#x000a0;min, respectively.</p><p>The effect of <italic>D.&#x000a0;kotschyi</italic> essential oil against <italic>Toxoplasma</italic> was highly significant compared to the negative control (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;.05). Besides, a significant difference was found between the essential oil of <italic>D.&#x000a0;kotschyi</italic> and the positive control after different exposure times and at all concentrations.</p></sec><sec id="fsn32021-sec-0020"><label>3.4</label><title>Light microscopy of morphology tachyzoites in Vero cell lines</title><p>The effects of increasing concentrations of <italic>D.&#x000a0;kotschyi</italic> essential oil treatment on <italic>T.&#x000a0;gondii</italic> in Vero cells were investigated by light microscopy (Figure&#x000a0;<xref rid="fsn32021-fig-0003" ref-type="fig">3</xref>). It shows the morphological effects of RPMI&#x02010;1640, positive control, and essential oil of <italic>D.&#x000a0;kotschyi</italic> on Vero cell and <italic>T.&#x000a0;gondii</italic>&#x02010;inoculated Vero cells. The number of tachyzoites decreased sharply from 1&#x000a0;&#x000b5;g to 1,000&#x000a0;&#x000b5;g of essential oil compared to the positive and negative control. The test was performed on tachyzoites from peritoneal exudates using Giemsa staining. Considerable numbers of the collected tachyzoites from all treated subgroups were reduced (Figure&#x000a0;<xref rid="fsn32021-fig-0003" ref-type="fig">3</xref>). Microscopic observation of intracellular parasite postinfection treatment was performed. Treatment of infected cells with <italic>D.&#x000a0;kotschyi</italic> essential oil, treatment with the positive control, and negative control are shown in Figure&#x000a0;<xref rid="fsn32021-fig-0003" ref-type="fig">3</xref>. Vero cells showed no remarkable morphological changes.</p><fig fig-type="Figure" xml:lang="en" id="fsn32021-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Light microscopy images of Vero cells, stained with modified Giemsa, are shown in different groups. The regular rosette arrangement of the intracellular tachyzoite, as seen in the negative control, was lost in the group treated with<italic>D.&#x000a0;kotschyi</italic>essential oil. The tachyzoites were shown with arrows.</p></caption><graphic id="nlm-graphic-7" xlink:href="FSN3-9-522-g003"/></fig></sec><sec id="fsn32021-sec-0021"><label>3.5</label><title>In vivo toxoplasmicidal studies and survival rate</title><p>The mice were observed daily, with observations recorded 14&#x000a0;days after treatment. From the fourth&#x02010;day postinfection, progressive mortality was recorded in the infected, untreated groups. By the sixth day, all mice were carried in this batch. In the group of infected mice. Mice treated with 50, 100, and 200&#x000a0;mg&#x000a0;kg<sup>&#x02212;1</sup>&#x000a0;day<sup>&#x02212;1</sup> of <italic>D.&#x000a0;kotschyi</italic> essential oil, the mice started to die on the 8th, 8th, and 12th day after treatment, respectively. Mice of sulfadiazine groups (positive group) began to die on the sixth day until the seventh day. Mice of pyrimethamine groups started to die on the seventh day until the ninth day, and the mice of <italic>D.&#x000a0;kotschyi</italic> essential oil groups began to die on the eighth day until the fourteenth day. A significant difference in the survival time between all treatment subgroups was observed. The treatment with <italic>D.&#x000a0;kotschyi</italic> essential oil (200&#x000a0;mg&#x000a0;kg<sup>&#x02212;1</sup>&#x000a0;day<sup>&#x02212;1</sup>) leads to better results in mice survival than treatment with <italic>D.&#x000a0;kotschyi</italic> essential oil (50 and 100&#x000a0;mg&#x000a0;kg<sup>&#x02212;1</sup>&#x000a0;day<sup>&#x02212;1</sup>). Mice in the treatment groups of <italic>D.&#x000a0;kotschyi</italic> essential oil (50, 100, and 200&#x000a0;mg&#x000a0;kg<sup>&#x02212;1</sup>&#x000a0;day<sup>&#x02212;1</sup>) showed a statistically higher survival rate compared to untreated infected control (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;.05). There was a significant difference between <italic>D.&#x000a0;kotschyi</italic> essential oil (50, 100, and 200&#x000a0;mg&#x000a0;kg<sup>&#x02212;1</sup>&#x000a0;day<sup>&#x02212;1</sup>) groups with positive control (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;.05) (Figure&#x000a0;<xref rid="fsn32021-fig-0004" ref-type="fig">4</xref>).</p><fig fig-type="Figure" xml:lang="en" id="fsn32021-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>The survival curves of mice following acute toxoplasmosis. Balb/c mice infected with<italic>T.&#x000a0;gondii</italic>RH strain were treated with<italic>D.&#x000a0;kotschyi</italic>essential oil, Sulfadiazine, and Pyrimethamine</p></caption><graphic id="nlm-graphic-9" xlink:href="FSN3-9-522-g004"/></fig></sec></sec><sec sec-type="discussion" id="fsn32021-sec-0022"><label>4</label><title>DISCUSSION</title><p>Studies to explore alternative treatments for toxoplasmosis are limited, particularly those involving medicinal plants. In the sphere of natural substance enhancement against toxoplasmosis, there are no data on the essential oils of <italic>D.&#x000a0;kotschyi</italic>. In this study, we evaluated the effect of treatment with <italic>D.&#x000a0;kotschyi</italic> on <italic>T.&#x000a0;gondii</italic> infection in vivo and in vitro. Various studies have evaluated the anti&#x02010;<italic>Toxoplasma</italic> effects of many herbal extracts in vitro and in vivo, but research on relatively useful and low toxicity substances is still needed (Al Nasr et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0002" ref-type="ref">2016</xref>; Arab&#x02010;Mazar et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0003" ref-type="ref">2017</xref>; Montazeri et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0030" ref-type="ref">2017</xref>; Sharif et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0041" ref-type="ref">2016</xref>).</p><p>The essential oil of <italic>D.&#x000a0;kotschyi</italic> had potent anti&#x02010;<italic>T.&#x000a0;gondii</italic>&#x000a0;activity. It exhibited cytotoxic effects against many cell lines tested and showed a more significant preferential cytotoxic effect of <italic>T.&#x000a0;gondii</italic>&#x000a0;tachyzoites, on all cell lines tested. Effective treatment for <italic>T.&#x000a0;gondii</italic> has remained unavailable for decodes even as new drugs continue to enter the market. These data are of interest, particularly with a view to the development of new therapies (Konstantinovic et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0024" ref-type="ref">2019</xref>).</p><p>The essential oil had an inhibitory action on the multiplication of the parasite with an IC<sub>50</sub> of 9.94&#x000a0;&#x000b5;g&#x000a0;&#x003bc;g/ml. The reduction in the number of <italic>T.&#x000a0;gondii</italic> tachyzoites was concentration&#x02010;dependent. In a previous study, the anti&#x02010;<italic>T.&#x000a0;gondii</italic> activity of nutmeg essential oil was demonstrated with an EC<sub>50</sub> value of 24.49&#x000a0;&#x000b5;g&#x000a0;&#x003bc;g/ml. Other studies have shown that the extract of <italic>D.&#x000a0;kotschyi</italic> had antimicrobial activities but also cytotoxicity toward cancer cells. Furthermore, according to these earlier studies, essential oils of <italic>D.&#x000a0;kotschyi</italic> were more potent against Gram&#x02010;positive bacteria (Orlanda &#x00026; Nascimento,&#x000a0;<xref rid="fsn32021-bib-0032" ref-type="ref">2015</xref>). The essential plant oil was thought to have effects on parasites such as <italic>T.&#x000a0;gondii</italic>&#x000a0;tachyzoites, and this was proved in the current study. Although further tests on its efficacy at large scales are necessary, the present study shows the potential of <italic>D.&#x000a0;kotschy</italic> essential oil as an alternative treatment. These in vitro pharmacological data attribute to the essential oil a potent anti&#x02010;<italic>T.&#x000a0;gondii</italic> activity coupled with an absence of toxicity to the host. There are no previous published studies on the effect of the essential oil against the RH strain of <italic>T.&#x000a0;gondii</italic> in a mouse model. In this study, the mouse model, we found that essential oil significantly reduced the parasite number.</p><p>Cytotoxicity assays showed that <italic>D.&#x000a0;kotschy</italic> was not cytotoxic to Vero cells. This result is consistent with that obtained in a previous study (Sharif et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0040" ref-type="ref">2019</xref>) with ethanolic extract of&#x000a0;<italic>Tinospora crispa</italic>. Furthermore, <italic>D.&#x000a0;kotschyi</italic> protected mice with acute toxoplasmosis from death to a certain extent and increased the survival in mice in vivo. In a study conducted by Pillai et al., the essential oil of Nutmeg (<italic>Myristica fragrans</italic> Houtt) showed strong anti&#x02010;<italic>T.&#x000a0;gondii</italic> activity beside low toxicity against a normal cell line (Pillai et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0034" ref-type="ref">2012</xref>). Our results showed that&#x000a0;<italic>D.&#x000a0;kotschyi</italic> is active against tachyzoites of&#x000a0;<italic>T.&#x000a0;gondii</italic> in vitro, and the tachizoitocidal effects of essential oil were significantly better than control. There was a significant difference between&#x000a0;essential oil of <italic>D.&#x000a0;kotschyi</italic> and control groups in all exposure times.</p><p>So far, several studies have been carried out on the therapeutic potential of natural products against <italic>T.&#x000a0;gondii</italic> (Kavitha et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0022" ref-type="ref">2012</xref>; Devanthran et al., <xref rid="fsn32021-bib-0011" ref-type="ref">2017</xref>; Ahmadpour et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0001" ref-type="ref">2019</xref>). For example, Devanthran et al. (2017) showed significant anti&#x02010;<italic>Toxoplasma</italic> activity of <italic>Piper sarmentosum</italic> ethanol extract (IC<sub>50</sub>&#x000a0;=&#x000a0;12.4&#x000a0;&#x003bc;g/mL). Also, after 24&#x000a0;hr of exposure to the extract, inoculated Vero cells exhibited low parasitemia associated with no specific morphological changes (Devanthran et al., 2017). As for Ahmadpour et&#x000a0;al.&#x000a0;(<xref rid="fsn32021-bib-0001" ref-type="ref">2019</xref>), they demonstrated the highly significant anti&#x02010;<italic>Toxoplasma</italic> effect of methanolic extracts of <italic>Zea mays</italic> and <italic>Eryngium caucasicum</italic>. <italic>Z.&#x000a0;mays</italic> (10, 25, and 50&#x000a0;mg/ml) killed 100% of the parasites after 180 and 120&#x000a0;min of exposure, respectively. Besides, the treatment of mice experimentally infected with <italic>Z.&#x000a0;mays</italic> (100, 200&#x000a0;mg&#x000a0;kg<sup>&#x02212;1</sup>&#x000a0;day<sup>&#x02212;1</sup>) and <italic>E.&#x000a0;caucasicum</italic> (100&#x000a0;mg&#x000a0;kg<sup>&#x02212;1</sup>&#x000a0;day<sup>&#x02212;1</sup>) significantly increased their survival rate compared to untreated infected mice (Ahmadpour et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0001" ref-type="ref">2019</xref>). All these results agree with the findings of the current study.</p><p>Another study by Moine et al. showed strong in vitro activity of eight compounds with a biphenylimidazoazine scaffold against <italic>T.&#x000a0;gondii</italic>, with a 50% effective concentration (EC<sub>50</sub>) below 1&#x000a0;mM, coupled with an absence of toxicity on human fibroblast cells. However, in vivo, investigations are necessary to confirm the activity of these compounds (Moine et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0029" ref-type="ref">2015</xref>).</p><p>Evaluation of anti&#x02010;<italic>T.&#x000a0;gondii</italic> effects of <italic>D.&#x000a0;kotschyi</italic> in mice acutely infected by the RH strain of <italic>T.&#x000a0;gondii</italic> had survived at 14&#x000a0;days post&#x02010;treatment. Our study showed that the essential oil of <italic>D.&#x000a0;kotschyi</italic> could inhibit&#x000a0;<italic>T.&#x000a0;gondii</italic>&#x000a0;in mice. These results are consistent with other studies (Choi et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0007" ref-type="ref">2013</xref>; Kareshk et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0020" ref-type="ref">2015</xref>; Leesombun et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0026" ref-type="ref">2016</xref>; de Oliveira et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0012" ref-type="ref">2009</xref>). Leesombun et&#x000a0;al.&#x000a0;(<xref rid="fsn32021-bib-0026" ref-type="ref">2016</xref>) reported that <italic>Thai piperaceae</italic> extracts inhibited the proliferation of&#x000a0;<italic>T.&#x000a0;gondii</italic>&#x000a0;tachyzoites (Leesombun et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0026" ref-type="ref">2016</xref>). Also, Kareshk et&#x000a0;al.&#x000a0;(<xref rid="fsn32021-bib-0020" ref-type="ref">2015</xref>) showed that the essential oil of <italic>Bunium persicum</italic> (0.1&#x000a0;ml/kg) reduced significantly mean several parasites compared to the control one (Kareshk et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0020" ref-type="ref">2015</xref>). Moreover, the results by Choi et al., showed that <italic>Zingiber offcinale</italic> (Ginger) extract courses improved the survival of infected mice and also inhibited the inflammatory response (Choi et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0007" ref-type="ref">2013</xref>).</p><p>Choi <italic>et al</italic>. reported that, 3&#x02010;[{2&#x02010;((E)&#x02010;furan&#x02010;2&#x02010;ylmethylene) hydrazinyl}methylene]&#x02010;1,3&#x02010;dihydroindol&#x02010;2&#x02010;one (ATT&#x02010;5126) and 6&#x02010;trifluoromethyl&#x02010;2&#x02010;thiouracil (KH&#x02010;0562) showed higher selectivity index compared with Pyrimethamine (PYR) in treatment of toxoplasmosis (Choi et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0006" ref-type="ref">2014</xref>). Also, Zhang <italic>et al</italic>. indicated that SI of Martine and Oxymartine parasite were higher compared with spiramycin in HeLa cells (Zhang et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0046" ref-type="ref">2016</xref>). The present study demonstrates that the essential oil of <italic>D.&#x000a0;kotschyi</italic> contains compounds possessing anti&#x02010;parasite properties. The presence of copaene, methyl geranate, geranial, carvone, 3&#x02010;carene, alpha&#x02010;pinene, limonene, and carveol compounds in these plants may be responsible for their anti&#x02010;parasitic&#x000a0;effect&#x000a0;on&#x000a0;<italic>T.&#x000a0;gondii</italic>&#x000a0;infection. Traditionally, the plant has long been used for therapeutic purposes (Heydari et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0017" ref-type="ref">2019</xref>).</p><p>The activity of the essential oil is due to the quality of the active molecules present in the essential oil. The previous study reported the presence of active compounds in the plant extract or oil. Shakib et&#x000a0;al.&#x000a0;(<xref rid="fsn32021-bib-0039" ref-type="ref">2018</xref>) found that <italic>D.&#x000a0;kotschyi</italic> essential oils contain Oxygenated Sesquiterpenes, Monoterpene Hydrocarbons, Sesquiterpene Hydrocarbons, and Oxygenated Monoterpenes. Flavoinoids such as calycopterin, acacetin 7&#x02010;O&#x02010;&#x003b2;&#x02010;<sc>d</sc>&#x02010;glucopyranoside, xanthomicrol, apigenin 4&#x02032;&#x02010;O&#x02010;&#x003b2;&#x02010;<sc>d</sc>&#x02010;glucopyranoside, isokaempferide, luteolin 3&#x02032;&#x02010;O&#x02010;&#x003b2;&#x02010;<sc>d</sc>&#x02010;glucuronide, luteolin, luteolin 7&#x02010;O&#x02010;&#x003b2;&#x02010;<sc>d</sc>&#x02010;glucopyranoside, apigenin have also been identified (Fattahi &#x00026; Nazeri,&#x000a0;<xref rid="fsn32021-bib-0014" ref-type="ref">2013</xref>; Saeidnia et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0038" ref-type="ref">2004</xref>, <xref rid="fsn32021-bib-0037" ref-type="ref">2005</xref>; Zeng et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0045" ref-type="ref">2010</xref>).</p><p>Our results further suggest that essential oil treatment may also induce dose&#x02010;dependent decreases in the ATP levels in&#x000a0;<italic>T.&#x000a0;gondii</italic>. This suggests that the mechanism of action of the essential oil against <italic>T.&#x000a0;gondii</italic> could involve interference with the mitochondrial function of the parasite (Zhou et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0047" ref-type="ref">2019</xref>). Besides, <italic>T.&#x000a0;gondii</italic> tachyzoites have only one mitochondrion, unlike mammalian cells (Melo et&#x000a0;al.,&#x000a0;<xref rid="fsn32021-bib-0028" ref-type="ref">2000</xref>); therefore, mitochondrial damage can disrupt energy metabolism by inhibiting the supply of energy in <italic>T.&#x000a0;gondii</italic> tachyzoites, leading to their death. Confirming this, anti&#x02010;<italic>Toxoplasma gondii</italic>, under a microscope, the number of tachyzoites showed a sharp decrease from 1&#x003bc;g to 1,000&#x000a0;&#x000b5;g compared to control. However, the specific mechanism of action needs to be further investigated.</p></sec><sec sec-type="conclusions" id="fsn32021-sec-0023"><label>5</label><title>CONCLUSIONS</title><p>We report for the first time anti&#x02010;<italic>Toxoplasma</italic> activity of <italic>Dracocephalum kotschyi</italic>, in vitro, and in vivo. The results obtained in this study attribute to the essential oil of <italic>D.&#x000a0;kotschyi</italic>, inhibitory activity against <italic>T.&#x000a0;gondii</italic>, without toxicity to the host. It can be assumed that the mechanism of action of the essential oil against <italic>T.&#x000a0;gondii</italic> is associated with the mitochondrial function of <italic>T.&#x000a0;gondii</italic>. The essential oil of <italic>D.&#x000a0;kotschyi</italic> has an interesting pharmacological potential to be valued in the fight against toxoplasmosis. Supplementary works are necessary to identify actives compounds associated with anti&#x02010;<italic>Toxoplasma activity</italic>.</p></sec><sec sec-type="COI-statement" id="fsn32021-sec-0025"><title>CONFLICT OF INTEREST</title><p>The authors declare that they do not have any conflict of interest.</p></sec></body><back><ack id="fsn32021-sec-0024"><title>ACKNOWLEDGMENTS</title><p>The authors also would like to express their special thanks to Dr. Fatemeh Namdar for her kind supports and assistance throughout all aspects of the methods section of our study.</p></ack><ref-list content-type="cited-references" id="fsn32021-bibl-0001"><title>REFERENCES</title><ref id="fsn32021-bib-0001"><mixed-citation publication-type="journal" id="fsn32021-cit-0001">
<string-name>
<surname>Ahmadpour</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Ebrahimzadeh</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Sharif</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Edalatian</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Sarvi</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Montazeri</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Mehrzadi</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Akbari</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Rahimi</surname>, <given-names>M. T.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Daryani</surname>, <given-names>A.</given-names>
</string-name> (<year>2019</year>). <article-title>Anti&#x02010;<italic>Toxoplasma</italic> Activities of <italic>Zea Mays</italic> and <italic>Eryngium Caucasicum</italic> Extracts, <italic>In vitro</italic> and <italic>in vivo</italic>
</article-title>. <source xml:lang="en">Journal of Pharmacopuncture</source>, <volume>22</volume>(<issue>3</issue>), <fpage>154</fpage>&#x02013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.3831/KPI.2019.22.020</pub-id>
<pub-id pub-id-type="pmid">31673445</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0002"><mixed-citation publication-type="journal" id="fsn32021-cit-0002">
<string-name>
<surname>Al Nasr</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Ahmed</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Pullishery</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>El&#x02010;Ashram</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Ramaiah</surname>, <given-names>V. V.</given-names>
</string-name> (<year>2016</year>). <article-title>Toxoplasmosis and anti&#x02010;<italic>Toxoplasma</italic> effects of medicinal plant extracts&#x02010;A mini&#x02010;review</article-title>. <source xml:lang="en">Asian Pacific Journal of Tropical Medicine</source>, <volume>9</volume>(<issue>8</issue>), <fpage>730</fpage>&#x02013;<lpage>734</lpage>. <pub-id pub-id-type="doi">10.1016/j.apjtm.2016.06.012</pub-id>
<pub-id pub-id-type="pmid">27569880</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0003"><mixed-citation publication-type="journal" id="fsn32021-cit-0003">
<string-name>
<surname>Arab&#x02010;Mazar</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Kheirandish</surname>, <given-names>F.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Rajaeian</surname>, <given-names>S.</given-names>
</string-name> (<year>2017</year>). <article-title>Anti&#x02010;toxoplasmosis activity of herbal medicines: Narrative review</article-title>. <source xml:lang="en">Herbal Medicines Journal</source>, <volume>2</volume>(<issue>1</issue>), <fpage>43</fpage>&#x02013;<lpage>49</lpage>.</mixed-citation></ref><ref id="fsn32021-bib-0004"><mixed-citation publication-type="journal" id="fsn32021-cit-0004">
<string-name>
<surname>Bajelan</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Bahreini</surname>, <given-names>M. S.</given-names>
</string-name>, <string-name>
<surname>Asgari</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Mikaeili</surname>, <given-names>F.</given-names>
</string-name> (<year>2020</year>). <article-title>Viability and infectivity of <italic>Toxoplasma gondii</italic> tachyzoites exposed to <italic>Butanedione monoxime</italic>
</article-title>. <source xml:lang="en">Journal of Parasitic Diseases</source>, <pub-id pub-id-type="doi">10.1007/s12639-020-01259-9</pub-id>
</mixed-citation></ref><ref id="fsn32021-bib-0005"><mixed-citation publication-type="journal" id="fsn32021-cit-0005">
<string-name>
<surname>Belloni</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Villena</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Gomez</surname>, <given-names>J. E.</given-names>
</string-name>, <string-name>
<surname>Pelloux</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Bonhomme</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Guenounou</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Pinon</surname>, <given-names>J. M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Aubert</surname>, <given-names>D.</given-names>
</string-name> (<year>2003</year>). <article-title>Regulation of tumor necrosis factor alpha and its specific receptors during <italic>Toxoplasma gondii</italic> infection in human monocytic cells</article-title>. <source xml:lang="en">Parasitology Research</source>, <volume>89</volume>, <fpage>207</fpage>&#x02013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1007/s00436-002-0735-z</pub-id>
<pub-id pub-id-type="pmid">12541063</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0006"><mixed-citation publication-type="journal" id="fsn32021-cit-0006">
<string-name>
<surname>Choi</surname>, <given-names>H. J.</given-names>
</string-name>, <string-name>
<surname>Yu</surname>, <given-names>S. T.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>K. I.</given-names>
</string-name>, <string-name>
<surname>Choi</surname>, <given-names>J. K.</given-names>
</string-name>, <string-name>
<surname>Chang</surname>, <given-names>B. Y.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>S. I.</given-names>
</string-name>, <string-name>
<surname>Ko</surname>, <given-names>M. H.</given-names>
</string-name>, <string-name>
<surname>Song</surname>, <given-names>H. O.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Park</surname>, <given-names>H.</given-names>
</string-name> (<year>2014</year>). <article-title>6&#x02010;trifluoromethyl&#x02010;2&#x02010;thiouracil possesses anti&#x02010;<italic>Toxoplasma gondii</italic> effect <italic>in vitro</italic> and <italic>in vivo</italic> with low hepatotoxicity</article-title>. <source xml:lang="en">Experimental Parasitology</source>, <volume>143</volume>, <fpage>24</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.exppara.2014.05.002</pub-id>
<pub-id pub-id-type="pmid">24830752</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0007"><mixed-citation publication-type="journal" id="fsn32021-cit-0007">
<string-name>
<surname>Choi</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>, <given-names>M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Chu</surname>, <given-names>J.</given-names>
</string-name> (<year>2013</year>). <article-title>Antiparasitic effects of <italic>Zingiber officinale</italic> (Ginger) extract against <italic>Toxoplasma gondii</italic>
</article-title>. <source xml:lang="en">Journal of Applied Biomedicine</source>, <volume>11</volume>(<issue>1</issue>), <fpage>15</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.2478/v10136-012-0014-y</pub-id>
</mixed-citation></ref><ref id="fsn32021-bib-0008"><mixed-citation publication-type="journal" id="fsn32021-cit-0008">
<string-name>
<surname>Cover</surname>, <given-names>B.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Gutteridge</surname>, <given-names>W. E.</given-names>
</string-name> (<year>1982</year>). <article-title>A primary screen for drugs to prevent transmission of Chagas's disease during blood transfusion</article-title>. <source xml:lang="en">Transactions of the Royal Society of Tropical Medicine and Hygiene</source>, <volume>76</volume>, <fpage>633</fpage>&#x02013;<lpage>635</lpage>. <pub-id pub-id-type="doi">10.1016/0035-9203(82)90228-0</pub-id>
<pub-id pub-id-type="pmid">6817479</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0009"><mixed-citation publication-type="journal" id="fsn32021-cit-0009">
<string-name>
<surname>Daryani</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Ebrahimzadeh</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Taheri</surname>, <given-names>M. M.</given-names>
</string-name>, <string-name>
<surname>Ahmadpour</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Montazeri</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Sarvi</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Akbari</surname>, <given-names>M.</given-names>
</string-name> (<year>2017</year>). <article-title>Anti&#x02010;<italic>Toxoplasma</italic> Effects of Methanol Extracts of <italic>Feijoa sellowiana</italic>, <italic>Quercus castaneifolia</italic>, and <italic>Allium paradoxum</italic>
</article-title>. <source xml:lang="en">Journal of Pharmacopuncture</source>, <volume>20</volume>(<issue>3</issue>), <fpage>220</fpage>&#x02013;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.3831/kpi.2017.20.026</pub-id>
<pub-id pub-id-type="pmid">30087799</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0010"><mixed-citation publication-type="journal" id="fsn32021-cit-0010">
<string-name>
<surname>De La Torre</surname>, <given-names>A. R.</given-names>
</string-name>, <string-name>
<surname>Birol</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Bousquet</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Ingvarsson</surname>, <given-names>P. K.</given-names>
</string-name>, <string-name>
<surname>Jansson</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Jones</surname>, <given-names>S. J. M.</given-names>
</string-name>, <string-name>
<surname>Keeling</surname>, <given-names>C. I.</given-names>
</string-name>, <string-name>
<surname>MacKay</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Nilsson</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<surname>Ritland</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Street</surname>, <given-names>N.</given-names>
</string-name> (<year>2014</year>). <article-title>Insights into conifer giga&#x02010;genomes</article-title>. <source xml:lang="en">Plant Physiology</source>, <volume>166</volume>, <fpage>1</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="fsn32021-bib-0011"><mixed-citation publication-type="journal" id="fsn32021-cit-0011">
<string-name>
<surname>Devanthran</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Unyah</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Abdul Majid</surname>, <given-names>R.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Omar Abdullah</surname>, <given-names>W.</given-names>
</string-name> (<year>2017</year>). <article-title>In vitro activity of <italic>Piper sarmentosum</italic> ethanol leaf extract against <italic>Toxoplasma gondii</italic> tachyzoites</article-title>. <source xml:lang="en">Tropical Journal of Pharmaceutical Research</source>, <volume>16</volume>(<issue>11</issue>), <fpage>2667</fpage>&#x02013;<lpage>2673</lpage>.</mixed-citation></ref><ref id="fsn32021-bib-0012"><mixed-citation publication-type="journal" id="fsn32021-cit-0012">
<string-name>
<surname>de Oliveira</surname>, <given-names>T. C.</given-names>
</string-name>, <string-name>
<surname>Silva</surname>, <given-names>D. A. O.</given-names>
</string-name>, <string-name>
<surname>Rostkowska</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>B&#x000e9;la</surname>, <given-names>S. R.</given-names>
</string-name>, <string-name>
<surname>Ferro</surname>, <given-names>E. A.</given-names>
</string-name>, <string-name>
<surname>Magalh&#x000e3;es</surname>, <given-names>P. M.</given-names>
</string-name>, <string-name>
<surname>Mineo</surname>, <given-names>J. R.</given-names>
</string-name> (<year>2009</year>). <article-title>
<italic>Toxoplasma gondii</italic>: Effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo</article-title>. <source xml:lang="en">Experimental Parasitology</source>, <volume>122</volume>(<issue>3</issue>), <fpage>233</fpage>&#x02013;<lpage>241</lpage>.<pub-id pub-id-type="pmid">19389400</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0013"><mixed-citation publication-type="journal" id="fsn32021-cit-0013">
<string-name>
<surname>Dunay</surname>, <given-names>I. R.</given-names>
</string-name>, <string-name>
<surname>Gajurel</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Dhakal</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Liesenfeld</surname>, <given-names>O.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Montoya</surname>, <given-names>J. G.</given-names>
</string-name> (<year>2018</year>). <article-title>Treatment of toxoplasmosis: Historical perspective, animal models, and current clinical practice</article-title>. <source xml:lang="en">Clinical Microbiology Reviews</source>, <volume>31</volume>, <fpage>e00057</fpage>&#x02013;<lpage>e117</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00057-17</pub-id>
<pub-id pub-id-type="pmid">30209035</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0014"><mixed-citation publication-type="journal" id="fsn32021-cit-0014">
<string-name>
<surname>Fattahi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Nazeri</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Torras&#x02010;Claveria</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Sefidkon</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Cusido</surname>, <given-names>R. M.</given-names>
</string-name>, <string-name>
<surname>Zamani</surname>, <given-names>Z.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Palazon</surname>, <given-names>J.</given-names>
</string-name> (<year>2013</year>). <article-title>Identification and quantification of leaf surface flavonoids in wild&#x02010;growing populations of <italic>Dracocephalum kotschyi</italic> by LC&#x02010;DAD&#x02010;ESI&#x02010;MS</article-title>. <source xml:lang="en">Food Chemistry</source>, <volume>141</volume>(<issue>1</issue>), <fpage>139</fpage>&#x02013;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2013.03.019</pub-id>
<pub-id pub-id-type="pmid">23768339</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0015"><mixed-citation publication-type="journal" id="fsn32021-cit-0015">
<string-name>
<surname>Gohari</surname>, <given-names>A. R.</given-names>
</string-name>, <string-name>
<surname>Saeidnia</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Matsuo</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Uchiyama</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Yagura</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Ito</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Kiuchi</surname>, <given-names>F.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Honda</surname>, <given-names>G.</given-names>
</string-name> (<year>2003</year>). <article-title>Flavonoid constituents of <italic>Dracocephalum kotschyi</italic> growing in Iran and their trypanocidal activity</article-title>. <source xml:lang="en">Journal of Natural Medicines</source>, <volume>57</volume>(<issue>6</issue>), <fpage>250</fpage>&#x02013;<lpage>252</lpage>.</mixed-citation></ref><ref id="fsn32021-bib-0016"><mixed-citation publication-type="journal" id="fsn32021-cit-0016">
<string-name>
<surname>Guaraldo</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Villar</surname>, <given-names>B. B. D. L. F.</given-names>
</string-name>, <string-name>
<surname>Dur&#x000e3;o</surname>, <given-names>N. M. G.</given-names>
</string-name>, <string-name>
<surname>Louro</surname>, <given-names>V. C.</given-names>
</string-name>, <string-name>
<surname>Quintana</surname>, <given-names>M. D. S. B.</given-names>
</string-name>, <string-name>
<surname>Curi</surname>, <given-names>A. L. L.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Neves</surname>, <given-names>E. S.</given-names>
</string-name> (<year>2018</year>). <article-title>Ocular toxoplasmosis: Adverse reactions to treatment in a Brazilian cohort</article-title>. <source xml:lang="en">Transactions of the Royal Society of Tropical Medicine and Hygiene</source>, <volume>112</volume>, <fpage>188</fpage>&#x02013;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1093/trstmh/try040</pub-id>
<pub-id pub-id-type="pmid">29788193</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0017"><mixed-citation publication-type="journal" id="fsn32021-cit-0017">
<string-name>
<surname>Heydari</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Yavari</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Adibi</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Asghari</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Ghanadian</surname>, <given-names>S. M.</given-names>
</string-name>, <string-name>
<surname>Dida</surname>, <given-names>G. O.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Khamesipour</surname>, <given-names>F.</given-names>
</string-name> (<year>2019</year>). <article-title>Medicinal properties and active constituents of Dracocephalum kotschyi and its significance in Iran: A systematic review</article-title>. <source xml:lang="en">Evidence&#x02010;Based Complementary and Alternative Medicine</source>, 2019. <pub-id pub-id-type="doi">10.1155/2019/5607329</pub-id>
</mixed-citation></ref><ref id="fsn32021-bib-0018"><mixed-citation publication-type="journal" id="fsn32021-cit-0018">
<string-name>
<surname>Jalaei</surname>, <given-names>Z. M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Fattahi</surname>, <given-names>S. A.</given-names>
</string-name> (<year>2015</year>). <article-title>Allelopathic and insecticidal activities of essential oil of <italic>Dracocephalum kotschyi</italic> Boiss. from Iran: A new chemotype with highest limonene&#x02010;10&#x02010;al and limonene</article-title>. <source xml:lang="en">Industrial Crops and Products</source>, <volume>73</volume>, <fpage>109</fpage>&#x02013;<lpage>117</lpage>.</mixed-citation></ref><ref id="fsn32021-bib-0019"><mixed-citation publication-type="journal" id="fsn32021-cit-0019">
<string-name>
<surname>Javidnia</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Miri</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Fahham</surname>, <given-names>N.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Mehregan</surname>, <given-names>I.</given-names>
</string-name> (<year>2005</year>). <article-title>Composition of the Essential Oil of <italic>Dracocephalum kotschyi</italic> Boiss. from Iran</article-title>. <source xml:lang="en">Journal of Essential Oil Research</source>, <volume>17</volume>, <fpage>481</fpage>&#x02013;<lpage>482</lpage>. <pub-id pub-id-type="doi">10.1080/10412905.2005.9698970</pub-id>
</mixed-citation></ref><ref id="fsn32021-bib-0020"><mixed-citation publication-type="journal" id="fsn32021-cit-0020">
<string-name>
<surname>Kareshk</surname>, <given-names>A. T.</given-names>
</string-name>, <string-name>
<surname>Keyhani</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Mahmoudvand</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Oliaei</surname>, <given-names>R. T.</given-names>
</string-name>, <string-name>
<surname>Asadi</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Andishmand</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Azzizian</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Babaei</surname>, <given-names>Z.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Zia&#x02010;Ali</surname>, <given-names>N.</given-names>
</string-name> (<year>2015</year>). <article-title>Efficacy of the <italic>Bunium persicum</italic> (Boiss) Essential Oil against Acute Toxoplasmosis in Mice Model</article-title>. <source xml:lang="en">Iranian Journal of Parasitology</source>, <volume>10</volume>(<issue>4</issue>), <fpage>625</fpage>.<pub-id pub-id-type="pmid">26811730</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0022"><mixed-citation publication-type="journal" id="fsn32021-cit-0022">
<string-name>
<surname>Kavitha</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Noordin</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Chan</surname>, <given-names>K. L.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Sasidharan</surname>, <given-names>S.</given-names>
</string-name> (<year>2012</year>). <article-title>In vitro anti&#x02010;<italic>Toxoplasma gondii</italic> activity of root extract/fractions of <italic>Eurycoma longifolia</italic> Jack</article-title>. <source xml:lang="en">BMC Complementary Medicine and Therapies</source>, <volume>12</volume>, <fpage>91</fpage>
<pub-id pub-id-type="doi">10.1186/1472-6882-12-91</pub-id>
</mixed-citation></ref><ref id="fsn32021-bib-0023"><mixed-citation publication-type="journal" id="fsn32021-cit-0023">
<string-name>
<surname>Khamesipour</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Doosti</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Iranpour Mobarakeh</surname>, <given-names>H.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Komba</surname>, <given-names>E. V.</given-names>
</string-name> (<year>2014</year>). <article-title>
<italic>Toxoplasma gondii</italic> in Cattle, Camels and Sheep in Isfahan and Chaharmahal va Bakhtiary Provinces</article-title>. <source xml:lang="en">Iran. Jundishapur Journal of Microbiology</source>, <volume>7</volume>(<issue>6</issue>), <elocation-id>e17460</elocation-id>
<pub-id pub-id-type="doi">10.5812/jjm.17460</pub-id>
<pub-id pub-id-type="pmid">25371809</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0024"><mixed-citation publication-type="journal" id="fsn32021-cit-0024">
<string-name>
<surname>Konstantinovic</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Guegan</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>St&#x000e4;jner</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Belaz</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Robert&#x02010;Gangneux</surname>, <given-names>F.</given-names>
</string-name> (<year>2019</year>). <article-title>Treatment of Toxoplasmosis: Current options and future perspectives</article-title>. <source xml:lang="en">Food and Waterborne Parasitology</source>, <volume>15</volume>, <elocation-id>e00036</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.fawpar.2019.e00036</pub-id>
<pub-id pub-id-type="pmid">32095610</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0026"><mixed-citation publication-type="journal" id="fsn32021-cit-0026">
<string-name>
<surname>Leesombun</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Boonmasawai</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Shimoda</surname>, <given-names>N.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Nishikawa</surname>, <given-names>Y.</given-names>
</string-name> (<year>2016</year>). <article-title>Effects of extracts from <italic>Thai piperaceae</italic> plants against infection with <italic>Toxoplasma gondii</italic>
</article-title>. <source xml:lang="en">PLoS One</source>, <volume>11</volume>(<issue>5</issue>), <elocation-id>e0156116</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0156116</pub-id>
<pub-id pub-id-type="pmid">27213575</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0027"><mixed-citation publication-type="journal" id="fsn32021-cit-0027">
<string-name>
<surname>McAuley</surname>, <given-names>J. B.</given-names>
</string-name> (<year>2014</year>). <article-title>Congenital Toxoplasmosis</article-title>. <source xml:lang="en">Journal of the Pediatric Infectious Diseases Society</source>, <volume>3</volume>(<issue>suppl_1</issue>), <fpage>S30</fpage>&#x02013;<lpage>S35</lpage>. <pub-id pub-id-type="doi">10.1093/jpids/piu077</pub-id>
<pub-id pub-id-type="pmid">25232475</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0028"><mixed-citation publication-type="journal" id="fsn32021-cit-0028">
<string-name>
<surname>Melo</surname>, <given-names>E. J.</given-names>
</string-name>, <string-name>
<surname>Attias</surname>, <given-names>M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>De Souza</surname>, <given-names>W.</given-names>
</string-name> (<year>2000</year>). <article-title>The single mitochondrion of tachyzoites of <italic>Toxoplasma gondii</italic>
</article-title>. <source xml:lang="en">Journal of Structural Biology</source>, <volume>130</volume>, <fpage>27</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1006/jsbi.2000.4228</pub-id>
<pub-id pub-id-type="pmid">10806088</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0029"><mixed-citation publication-type="journal" id="fsn32021-cit-0029">
<string-name>
<surname>Moine</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Denevault&#x02010;Sabourin</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Debierre&#x02010;Grockiego</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Silpa</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Gorgette</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<surname>Barale</surname>, <given-names>J.&#x02010;C.</given-names>
</string-name>, <string-name>
<surname>Jacquiet</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Brossier</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Gueiffier</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Dimier&#x02010;Poisson</surname>, <given-names>I.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Enguehard&#x02010;Gueiffier</surname>, <given-names>C.</given-names>
</string-name> (<year>2015</year>). <article-title>A small&#x02010;molecule cell&#x02010;based screen led to the identification of biphenylimidazoazines with highly potent and broad&#x02010;spectrum anti&#x02010;apicomplexan activity</article-title>. <source xml:lang="en">European Journal of Medicinal Chemistry</source>, <volume>89</volume>, <fpage>386</fpage>&#x02013;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2014.10.057</pub-id>
<pub-id pub-id-type="pmid">25462254</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0030"><mixed-citation publication-type="journal" id="fsn32021-cit-0030">
<string-name>
<surname>Montazeri</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Sharif</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Sarvi</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Mehrzadi</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Ahmadpour</surname>, <given-names>E.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Daryani</surname>, <given-names>A.</given-names>
</string-name> (<year>2017</year>). <article-title>A systematic review of in vitro and in vivo activities of anti&#x02010;toxoplasma drugs and compounds (2006&#x02013;2016)</article-title>. <source xml:lang="en">Frontiers in Microbiology</source>, <volume>8</volume>, <fpage>25</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2017.00025</pub-id>
<pub-id pub-id-type="pmid">28163699</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0031"><mixed-citation publication-type="journal" id="fsn32021-cit-0031">
<string-name>
<surname>Mosmann</surname>, <given-names>T.</given-names>
</string-name> (<year>1983</year>). <article-title>Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay</article-title>. <source xml:lang="en">Journal of Immunological Methods</source>, <volume>65</volume>, <fpage>55</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">6606682</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0032"><mixed-citation publication-type="journal" id="fsn32021-cit-0032">
<string-name>
<surname>Orlanda</surname>, <given-names>J. F.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Nascimento</surname>, <given-names>A.</given-names>
</string-name> (<year>2015</year>). <article-title>Chemical composition and antibacterial activity of <italic>Ruta graveolens</italic> L (Rutaceae) volatile oils, from S&#x000e4;o Lu&#x000ed;s, Maranh&#x000e4;o, Brazil</article-title>. <source xml:lang="en">South African Journal of Botany</source>, <volume>99</volume>, <fpage>103</fpage>&#x02013;<lpage>106</lpage>.</mixed-citation></ref><ref id="fsn32021-bib-0033"><mixed-citation publication-type="journal" id="fsn32021-cit-0033">
<string-name>
<surname>Park</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>M. S.</given-names>
</string-name>, <string-name>
<surname>Jeon</surname>, <given-names>B. H.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>T. K.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>Y. M.</given-names>
</string-name>, <string-name>
<surname>Ahnn</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Kwon</surname>, <given-names>D. Y.</given-names>
</string-name>, <string-name>
<surname>Takaya</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Wataya</surname>, <given-names>Y.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Kimm</surname>, <given-names>H. S.</given-names>
</string-name> (<year>2003</year>). <article-title>Antimalarial activity of herbal extracts used in traditional medicine in Korea</article-title>. <source xml:lang="en">Biological and Pharmaceutical Bulletin</source>, <volume>26</volume>, <fpage>1623</fpage>&#x02013;<lpage>1624</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.26.1623</pub-id>
<pub-id pub-id-type="pmid">14600415</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0034"><mixed-citation publication-type="journal" id="fsn32021-cit-0034">
<string-name>
<surname>Pillai</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Mahmud</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>W. C.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Perumal</surname>, <given-names>S.</given-names>
</string-name> (<year>2012</year>). <article-title>Anti&#x02010;parasitic activity of <italic>Myristica fragrans</italic> Houtt. essential oil against <italic>Toxoplasma gondii</italic> parasite</article-title>. <source xml:lang="en">APCBEE Procedia</source>, <volume>2</volume>, <fpage>92</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.apcbee.2012.06.017</pub-id>
</mixed-citation></ref><ref id="fsn32021-bib-0035"><mixed-citation publication-type="journal" id="fsn32021-cit-0035">
<string-name>
<surname>Rajapakse</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Chrishan Shivanthan</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Samaranayake</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Rodrigo</surname>, <given-names>C.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Deepika Fernando</surname>, <given-names>S.</given-names>
</string-name> (<year>2013</year>). <article-title>Antibiotics for human toxoplasmosis: A systematic review of randomized trials. <italic>Pathogens and Global</italic>
</article-title>. <source xml:lang="en">Health</source>, <volume>107,162e169</volume>
<pub-id pub-id-type="doi">10.1179/2047773213Y.0000000094</pub-id>
</mixed-citation></ref><ref id="fsn32021-bib-0036"><mixed-citation publication-type="journal" id="fsn32021-cit-0036">
<string-name>
<surname>Sadraei</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Asghari</surname>, <given-names>G.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Alinejad</surname>, <given-names>M.</given-names>
</string-name> (<year>2016</year>). <article-title>Comparison of antispasmodic effect of hydroalcoholic extract of <italic>Dracocephalum kotschyi</italic> Boiss. in rat uterus and ileum. <italic>Research</italic>
</article-title>. <source xml:lang="en">Pharmaceutical Sciences</source>, <volume>11</volume>(<issue>4</issue>), <fpage>284</fpage>&#x02013;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.4103/1735-5362.189295</pub-id>
</mixed-citation></ref><ref id="fsn32021-bib-0037"><mixed-citation publication-type="journal" id="fsn32021-cit-0037">
<string-name>
<surname>Saeidnia</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Gohari</surname>, <given-names>A. R.</given-names>
</string-name>, <string-name>
<surname>Ito</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Kiuchi</surname>, <given-names>F.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Honda</surname>, <given-names>G.</given-names>
</string-name> (<year>2005</year>). <article-title>Bioactive constituents from <italic>Dracocephalum subcapitatum</italic> (O. Kuntze) lipsky. <italic>Zeitschrift f&#x000fc;r Naturforschung C. A</italic>
</article-title>. <source xml:lang="en">Journal of Biosciences</source>, <volume>60</volume>(<issue>1&#x02013;2</issue>), <fpage>22</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1515/znc-2005-1-204</pub-id>
<pub-id pub-id-type="pmid">15787238</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0038"><mixed-citation publication-type="journal" id="fsn32021-cit-0038">
<string-name>
<surname>Saeidnia</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Gohari</surname>, <given-names>A. R.</given-names>
</string-name>, <string-name>
<surname>Uchiyama</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Ito</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Honda</surname>, <given-names>G.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Kiuchi</surname>, <given-names>F.</given-names>
</string-name> (<year>2004</year>). <article-title>Two new monoterpene glycosides and trypanocidal terpenoids from <italic>Dracocephalum kotschyi</italic>
</article-title>. <source xml:lang="en">Chemical and Pharmaceutical Bulletin</source>, <volume>52</volume>(<issue>10</issue>), <fpage>1249</fpage>&#x02013;<lpage>1250</lpage>. <pub-id pub-id-type="doi">10.1248/cpb.52.1249</pub-id>
<pub-id pub-id-type="pmid">15467247</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0039"><mixed-citation publication-type="journal" id="fsn32021-cit-0039">
<string-name>
<surname>Shakib</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Taherikalani</surname>, <given-names>M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Ramazanzadeh</surname>, <given-names>R.</given-names>
</string-name> (<year>2018</year>). <article-title>Chemical composition, genotoxicity and antimicrobial activities of <italic>Dracocephalum kotschyi</italic> boiss against OXA&#x02010;48 producing <italic>Klebsiella pneumoniae</italic> isolated from major hospitals of Kurdistan Province</article-title>. <source xml:lang="en">Iran. Microbiology Research Journal International</source>, <volume>24</volume>, <fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.9734/MRJI/2018/42064</pub-id>
</mixed-citation></ref><ref id="fsn32021-bib-0040"><mixed-citation publication-type="journal" id="fsn32021-cit-0040">
<string-name>
<surname>Sharif</surname>, <given-names>A. A.</given-names>
</string-name>, <string-name>
<surname>Unyah</surname>, <given-names>N. Z.</given-names>
</string-name>, <string-name>
<surname>Nordin</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Basir</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Wana</surname>, <given-names>M. N.</given-names>
</string-name>, <string-name>
<surname>Alapid Ahmad</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Mustapha</surname>, <given-names>T.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Majid</surname>, <given-names>R. A.</given-names>
</string-name> (<year>2019</year>). <article-title>Susceptibility of Toxoplasma gondii to Ethanolic Extract of Tinospora crispa in Vero Cells</article-title>. <source xml:lang="en">Evidence&#x02010;Based Complementary and Alternative Medicine</source>, 2019, 2916547. <pub-id pub-id-type="doi">10.1155/2019/2916547</pub-id>
</mixed-citation></ref><ref id="fsn32021-bib-0041"><mixed-citation publication-type="journal" id="fsn32021-cit-0041">
<string-name>
<surname>Sharif</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Sarvi</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Pagheh</surname>, <given-names>A. S.</given-names>
</string-name>, <string-name>
<surname>Asfaram</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Rahimi</surname>, <given-names>M. T.</given-names>
</string-name>, <string-name>
<surname>Mehrzadi</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Ahmadpour</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Gholami</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Daryani</surname>, <given-names>A.</given-names>
</string-name> (<year>2016</year>). <article-title>The efficacy of herbal medicines against <italic>Toxoplasma gondii</italic> during the last 3 decades: A systematic review</article-title>. <source xml:lang="en">Canadian Journal of Physiology and Pharmacology</source>, <volume>94</volume>(<issue>12</issue>), <fpage>1237</fpage>&#x02013;<lpage>1248</lpage>. <pub-id pub-id-type="doi">10.1139/cjpp-2016-0039</pub-id>
<pub-id pub-id-type="pmid">27564395</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0042"><mixed-citation publication-type="journal" id="fsn32021-cit-0042">
<string-name>
<surname>Sheng&#x02010;Xia</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Liang</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Xu&#x02010;Gan</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Yao&#x02010;Yu</surname>, <given-names>F.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Jian&#x02010;Ping</surname>, <given-names>C.</given-names>
</string-name> (<year>2008</year>). <article-title>Anti&#x02010;<italic>Toxoplasma</italic> gondii activity of GAS <italic>in vitro</italic>
</article-title>. <source xml:lang="en">Journal of Ethnopharmacology</source>, <volume>118</volume>, <fpage>503</fpage>&#x02013;<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2008.05.023</pub-id>
<pub-id pub-id-type="pmid">18602775</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0043"><mixed-citation publication-type="journal" id="fsn32021-cit-0043">
<string-name>
<surname>Sonboli</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Mirzania</surname>, <given-names>F.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Gholipour</surname>, <given-names>A.</given-names>
</string-name> (<year>2019</year>). <article-title>Essential oil composition of <italic>Dracocephalum kotschyi</italic> Boiss. from Iran</article-title>. <source xml:lang="en">Natural Product Research</source>, <volume>33</volume>(<issue>14</issue>), <fpage>2095</fpage>&#x02013;<lpage>2098</lpage>.<pub-id pub-id-type="pmid">29873264</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0044"><mixed-citation publication-type="journal" id="fsn32021-cit-0044">
<string-name>
<surname>Weissmann</surname>, <given-names>J.</given-names>
</string-name> (<year>2003</year>). <article-title>Presumptive <italic>Toxoplasma gondii</italic> abortion in a sheep</article-title>. <source xml:lang="en">Canadian Veterinary Journal</source>, <volume>44</volume>, <fpage>322</fpage>&#x02013;<lpage>324</lpage>.</mixed-citation></ref><ref id="fsn32021-bib-0045"><mixed-citation publication-type="journal" id="fsn32021-cit-0045">
<string-name>
<surname>Zeng</surname>, <given-names>Q. I.</given-names>
</string-name>, <string-name>
<surname>Jin</surname>, <given-names>H.&#x02010;Z.</given-names>
</string-name>, <string-name>
<surname>Qin</surname>, <given-names>J.&#x02010;J.</given-names>
</string-name>, <string-name>
<surname>Fu</surname>, <given-names>J.&#x02010;J.</given-names>
</string-name>, <string-name>
<surname>Hu</surname>, <given-names>X.&#x02010;J.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>J.&#x02010;H.</given-names>
</string-name>, <string-name>
<surname>Yan</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Zhang</surname>, <given-names>W.&#x02010;D.</given-names>
</string-name> (<year>2010</year>). <article-title>Chemical constituents of plants from the genus <italic>Dracocephalum</italic>
</article-title>. <source xml:lang="en">Chemistry &#x00026; Biodiversity</source>, <volume>7</volume>(<issue>8</issue>), <fpage>1911</fpage>&#x02013;<lpage>1929</lpage>. <pub-id pub-id-type="doi">10.1002/cbdv.200900188</pub-id>
<pub-id pub-id-type="pmid">20730957</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0046"><mixed-citation publication-type="journal" id="fsn32021-cit-0046">
<string-name>
<surname>Zhang</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Jin</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Cui</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Wu</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Park</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Quan</surname>, <given-names>H.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Jin</surname>, <given-names>C.</given-names>
</string-name> (<year>2016</year>). <article-title>Antiparasitic effects of oxymatrine and matrine against <italic>Toxoplasma gondii in vitro</italic> and <italic>in vivo</italic>
</article-title>. <source xml:lang="en">Experimental Parasitology</source>, <volume>165</volume>, <fpage>95</fpage>&#x02013;<lpage>102</lpage>.<pub-id pub-id-type="pmid">26993085</pub-id></mixed-citation></ref><ref id="fsn32021-bib-0047"><mixed-citation publication-type="journal" id="fsn32021-cit-0047">
<string-name>
<surname>Zhou</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Puthiyakunnon</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>He</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Xia</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>He</surname>, <given-names>C. Y.</given-names>
</string-name>, <string-name>
<surname>Deng</surname>, <given-names>S. Q.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Peng</surname>, <given-names>H. J.</given-names>
</string-name> (<year>2019</year>). <article-title>
<italic>Toxoplasma gondii</italic> ROP18 inhibits human glioblastoma cell apoptosis through a mitochondrial pathway by targeting host cell P2X1</article-title>. <source xml:lang="en">Parasites &#x00026; Vectors</source>, <volume>12</volume>, <fpage>284</fpage>
<pub-id pub-id-type="doi">10.1186/s13071-019-3529-1</pub-id>
<pub-id pub-id-type="pmid">31164145</pub-id></mixed-citation></ref></ref-list></back></article>